Full Breakdown
Dr. Mehmet Oz Launches Investigation into New York's $124 Billion Medicaid Program
3/7/2026, 12:18:58 AM
Overview of the Investigation
Dr. Mehmet Oz, Administrator of the U.S. Centers for Medicare and Medicaid Services (CMS), has initiated a comprehensive investigation into New York's Medicaid program, which costs approximately $124 billion annually. In a letter addressed to Governor Kathy Hochul, Oz outlined 50 questions regarding the state's management of Medicaid, particularly focusing on issues of fraud, waste, and abuse. He emphasized that New York's Medicaid spending is significantly higher than the national average, with an average expenditure of $12,528 per beneficiary—36% above the national average.
Key Concerns Raised
Oz's inquiry highlights alarming trends in Medicaid spending, particularly in personal care services, adult day care, and non-emergency medical transportation. He pointed out that spending on personal care services has surged, with nearly three-quarters of Medicaid enrollees utilizing these services, raising questions about the legitimacy of such high utilization rates. Recent criminal cases, including a $68 million fraud scheme involving kickbacks for services not rendered, further underscore the vulnerabilities within the program.
Oz stated, “When the numbers don’t make sense, we ask hard questions, and we expect an honest answer,” indicating the urgency of the investigation. He has given the Hochul administration 30 days to respond with a corrective action plan or risk having federal payments deferred.
Official Statements & Responses
In response to Oz's investigation, Governor Hochul defended her administration's efforts to combat fraud, asserting that reforms have already saved over $2 billion by eliminating wasteful middlemen in the Consumer Directed Personal Assistance Program (CDPAP). Hochul's office characterized the federal scrutiny as politically motivated, suggesting that the Trump administration aims to undermine healthcare services for vulnerable populations. “Let’s be clear about the real goal for Donald Trump and Washington Republicans: eliminating programs that support our most vulnerable,” a spokesperson stated.
Criticism & Opposition
Critics of the Hochul administration, including New York Republicans, have welcomed the investigation, arguing that the state's Medicaid system has long lacked adequate oversight. Rep. Mike Lawler remarked, “This system needs a complete audit, and Dr. Oz is right to demand answers from the state.” Meanwhile, some Democratic officials have accused the Trump administration of using the investigation as a political tool against a Democratic-led state.
Conflicting Reports & Gaps
While Oz's investigation is framed as a necessary measure to ensure accountability, some state officials argue that the scrutiny is excessive and politically charged. Hochul's administration has pointed to previous efforts to reform Medicaid as evidence of their commitment to integrity, contrasting with the Trump administration's approach, which they claim is punitive.
What's Next
The outcome of this investigation could have significant implications for New York's Medicaid program and its beneficiaries. If the Hochul administration fails to provide satisfactory answers, CMS may begin deferring payments, which could jeopardize healthcare access for millions of New Yorkers. As the deadline approaches, the political landscape surrounding Medicaid in New York is likely to intensify, with both state and federal officials preparing for potential fallout.
Verbatim Quotes
- “The data is clear: New York far outspends other states on its Medicaid program on a statewide and per beneficiary basis,” — Dr. Mehmet Oz, CMS Administrator
- “When something doesn't add up, you don't ignore it — you investigate.” — Dr. Mehmet Oz, CMS Administrator
- “Well before the Trump administration even took office, Governor Hochul was leading efforts to root out waste, fraud and abuse,” — Hochul's spokesperson
This investigation marks a critical juncture in the ongoing dialogue about Medicaid funding and oversight in New York, with potential ramifications for healthcare policy nationwide.
